RenovoRx, Inc. (RNXT) NASDAQ

1.30

+0.03(+2.36%)

Updated at October 03 03:06PM

Currency In USD

RenovoRx, Inc.

Address

4546 El Camino Real

Mountain View, CA 94022

United States of America

Phone

650 284 4433

Sector

Healthcare

Industry

Biotechnology

Employees

10

First IPO Date

August 26, 2021

Key Executives

NameTitlePayYear Born
Mr. Shaun R. BagaiChief Executive Officer, Secretary & Director966,8281977
Dr. Ramtin Agah M.D.Founder, Chairman of Board & Chief Medical Officer473,4071966
Ms. Leesa GentryChief Clinical Officer532,5941970
Mr. Ryan WittSenior Vice President and Head of Corporate Strategy & Partnerships0N/A
Mr. Ronald B. Kocak CPA, CGMAVice President, Controller & Principal Accounting Officer01957
Mr. Robert StrasserVice President of Operations and R&D0N/A

Description

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.